73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers identify a protein that promotes cancer metastasis, providing a new potential treatment target

Researchers identify a protein that promotes cancer metastasis, providing a new potential treatment target

by City University of Hong KongThey also demonstrated that LH1 could bind and stabilize Septin2 (SEPT2), a protein that plays an essential role in preparing the cells for high mechanical migratio

Researchers identify a protein that promotes cancer metastasis, providing a new potential treatment target

by City University of Hong KongThey also demonstrated that LH1 could bind and stabilize Septin2 (SEPT2), a protein that plays an essential role in preparing the cells for high mechanical migratio
Novel PET radiotracer successfully detects multiple cancers, offers potential for new targeted radionuclide therapy

Novel PET radiotracer successfully detects multiple cancers, offers potential for new targeted radionuclide therapy

by Society of Nuclear Medicine and Molecular ImagingMaximum-intensity projection images of 18F-fluorodeoxyglucose (FDG), 68Ga-FAP-2286, and 68Ga-FAPI-46 PET/CT imaging in seven patients with different

Novel PET radiotracer successfully detects multiple cancers, offers potential for new targeted radionuclide therapy

by Society of Nuclear Medicine and Molecular ImagingMaximum-intensity projection images of 18F-fluorodeoxyglucose (FDG), 68Ga-FAP-2286, and 68Ga-FAPI-46 PET/CT imaging in seven patients with different
Manipulating mitochondrial shape may limit metastatic cancer, study finds

Manipulating mitochondrial shape may limit metastatic cancer, study finds

byUT Southwestern Medical CenterStudy leader Srinivas Malladi, Ph.D., (left) worked with postdoctoral researcher Pravat Kumar Parida, Ph.D., to investigate the changing shape of mitochondria in

Manipulating mitochondrial shape may limit metastatic cancer, study finds

byUT Southwestern Medical CenterStudy leader Srinivas Malladi, Ph.D., (left) worked with postdoctoral researcher Pravat Kumar Parida, Ph.D., to investigate the changing shape of mitochondria in
Appendiceal cancer gets its own preclinical model

Appendiceal cancer gets its own preclinical model

byUniversity of California - San DiegoConfocal image of a living tissue slice derived from a patient tumor with metastatic appendiceal cancer (mucinous carcinomatosis peritonei). Immunofluoresce

Appendiceal cancer gets its own preclinical model

byUniversity of California - San DiegoConfocal image of a living tissue slice derived from a patient tumor with metastatic appendiceal cancer (mucinous carcinomatosis peritonei). Immunofluoresce
Conspiracy believers more likely to endorse mythical causes of cancer, finds study

Conspiracy believers more likely to endorse mythical causes of cancer, finds study

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainPeople who believe in conspiracies, reject the COVID-19 vaccine, or prefer alternative medicine are more likely to endorse mythical caus

Conspiracy believers more likely to endorse mythical causes of cancer, finds study

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainPeople who believe in conspiracies, reject the COVID-19 vaccine, or prefer alternative medicine are more likely to endorse mythical caus
Researchers report encouraging immunotherapy option for relapsed myeloma patients

Researchers report encouraging immunotherapy option for relapsed myeloma patients

by The Mount Sinai HospitalTreatment breakdown of the multiple myeloma patient cohort. (A) Flow chart showing that the initial retrospective query yielded 115 RRMM patients enrolled on a BiAb cli

Researchers report encouraging immunotherapy option for relapsed myeloma patients

by The Mount Sinai HospitalTreatment breakdown of the multiple myeloma patient cohort. (A) Flow chart showing that the initial retrospective query yielded 115 RRMM patients enrolled on a BiAb cli
A new tool to screen drugs that target loss of tumor suppressor genes

A new tool to screen drugs that target loss of tumor suppressor genes

by Ludwig Cancer ResearchGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104437In a May publication iniScience, researchers led by Ludwig Johns Hopkins's

A new tool to screen drugs that target loss of tumor suppressor genes

by Ludwig Cancer ResearchGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104437In a May publication iniScience, researchers led by Ludwig Johns Hopkins's
Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainThe Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, c

Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainThe Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, c
CAR T-cell therapy proves effective in first trial in patients with resistant multiple myeloma

CAR T-cell therapy proves effective in first trial in patients with resistant multiple myeloma

by Roswell Park Comprehensive Cancer CenterCredit: CC0 Public DomainA therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impres

CAR T-cell therapy proves effective in first trial in patients with resistant multiple myeloma

by Roswell Park Comprehensive Cancer CenterCredit: CC0 Public DomainA therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impres
Blood cancer discovery identifies high-risk patients, could improve outcomes

Blood cancer discovery identifies high-risk patients, could improve outcomes

by Josh Barney,University of VirginiaUVA researchers say a new method of identifying acute myeloid leukemia patients likely to have a poor outcomes could eventually lead to improved treatment pl

Blood cancer discovery identifies high-risk patients, could improve outcomes

by Josh Barney,University of VirginiaUVA researchers say a new method of identifying acute myeloid leukemia patients likely to have a poor outcomes could eventually lead to improved treatment pl
Treatment decisions in new era of individualized therapy for metastatic hormone-sensitive prostate cancer

Treatment decisions in new era of individualized therapy for metastatic hormone-sensitive prostate cancer

byDana-Farber Cancer InstituteProstate cancer cells. Credit: NIH Image GalleryOncologists have traditionally prescribed androgen deprivation therapy (ADT) alone for patients with metastatic horm

Treatment decisions in new era of individualized therapy for metastatic hormone-sensitive prostate cancer

byDana-Farber Cancer InstituteProstate cancer cells. Credit: NIH Image GalleryOncologists have traditionally prescribed androgen deprivation therapy (ADT) alone for patients with metastatic horm
17-gene signature linked to remission after triple-negative breast cancer treatment

17-gene signature linked to remission after triple-negative breast cancer treatment

by Susan Murphy,Mayo ClinicCredit: CC0 Public DomainMayo Clinic researchers have discovered a distinctive pattern in a specific set of 17 genes that may be associated with remission after treatm

17-gene signature linked to remission after triple-negative breast cancer treatment

by Susan Murphy,Mayo ClinicCredit: CC0 Public DomainMayo Clinic researchers have discovered a distinctive pattern in a specific set of 17 genes that may be associated with remission after treatm